161 related articles for article (PubMed ID: 25598009)
1. In vitro and in vivo regulation of synaptogenesis by the novel antidepressant spadin.
Devader C; Khayachi A; Veyssière J; Moha Ou Maati H; Roulot M; Moreno S; Borsotto M; Martin S; Heurteaux C; Mazella J
Br J Pharmacol; 2015 May; 172(10):2604-17. PubMed ID: 25598009
[TBL] [Abstract][Full Text] [Related]
2. Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design.
Mazella J; Pétrault O; Lucas G; Deval E; Béraud-Dufour S; Gandin C; El-Yacoubi M; Widmann C; Guyon A; Chevet E; Taouji S; Conductier G; Corinus A; Coppola T; Gobbi G; Nahon JL; Heurteaux C; Borsotto M
PLoS Biol; 2010 Apr; 8(4):e1000355. PubMed ID: 20405001
[TBL] [Abstract][Full Text] [Related]
3. First evidence of protective effects on stroke recovery and post-stroke depression induced by sortilin-derived peptides.
Pietri M; Djillani A; Mazella J; Borsotto M; Heurteaux C
Neuropharmacology; 2019 Nov; 158():107715. PubMed ID: 31325429
[TBL] [Abstract][Full Text] [Related]
4. Spadin as a new antidepressant: absence of TREK-1-related side effects.
Moha Ou Maati H; Veyssiere J; Labbal F; Coppola T; Gandin C; Widmann C; Mazella J; Heurteaux C; Borsotto M
Neuropharmacology; 2012 Jan; 62(1):278-88. PubMed ID: 21807005
[TBL] [Abstract][Full Text] [Related]
5. TREK1 channel blockade induces an antidepressant-like response synergizing with 5-HT1A receptor signaling.
Ye D; Li Y; Zhang X; Guo F; Geng L; Zhang Q; Zhang Z
Eur Neuropsychopharmacol; 2015 Dec; 25(12):2426-36. PubMed ID: 26441141
[TBL] [Abstract][Full Text] [Related]
6. Hippocampal BDNF signaling restored with chronic asiaticoside treatment in depression-like mice.
Luo L; Liu XL; Mu RH; Wu YJ; Liu BB; Geng D; Liu Q; Yi LT
Brain Res Bull; 2015 May; 114():62-9. PubMed ID: 25857945
[TBL] [Abstract][Full Text] [Related]
7. Retroinverso analogs of spadin display increased antidepressant effects.
Veyssiere J; Moha Ou Maati H; Mazella J; Gaudriault G; Moreno S; Heurteaux C; Borsotto M
Psychopharmacology (Berl); 2015 Feb; 232(3):561-74. PubMed ID: 25080852
[TBL] [Abstract][Full Text] [Related]
8. Shortened Spadin Analogs Display Better TREK-1 Inhibition,
Djillani A; Pietri M; Moreno S; Heurteaux C; Mazella J; Borsotto M
Front Pharmacol; 2017; 8():643. PubMed ID: 28955242
[TBL] [Abstract][Full Text] [Related]
9. Blocking Two-Pore Domain Potassium Channel TREK-1 Inhibits the Activation of A1-Like Reactive Astrocyte Through the NF-κB Signaling Pathway in a Rat Model of Major Depressive Disorder.
Cong T; Sun Y; Zhou Y; Wu H; Li L; Chu Z; Chen X; Li J; Zhao D; Wang Y; Liu Y; Yin S; Xiao Z
Neurochem Res; 2023 Jun; 48(6):1737-1754. PubMed ID: 36670238
[TBL] [Abstract][Full Text] [Related]
10. Antidepressant and neuroprotective effect of the Chinese herb kaixinsan against lentiviral shRNA knockdown brain-derived neurotrophic factor-induced injury in vitro and in vivo.
Hu Y; Zhou XJ; Liu P; Dong XZ; Mu LH; Chen YB; Liu MY; Yu BY
Neuropsychobiology; 2014; 69(3):129-39. PubMed ID: 24776773
[TBL] [Abstract][Full Text] [Related]
11. Fighting against depression with TREK-1 blockers: Past and future. A focus on spadin.
Djillani A; Pietri M; Mazella J; Heurteaux C; Borsotto M
Pharmacol Ther; 2019 Feb; 194():185-198. PubMed ID: 30291907
[TBL] [Abstract][Full Text] [Related]
12. Brain-derived neurotrophic factor increases inhibitory synapses, revealed in solitary neurons cultured from rat visual cortex.
Palizvan MR; Sohya K; Kohara K; Maruyama A; Yasuda H; Kimura F; Tsumoto T
Neuroscience; 2004; 126(4):955-66. PubMed ID: 15207329
[TBL] [Abstract][Full Text] [Related]
13. SKF83959 produces antidepressant effects in a chronic social defeat stress model of depression through BDNF-TrkB pathway.
Jiang B; Wang F; Yang S; Fang P; Deng ZF; Xiao JL; Hu ZL; Chen JG
Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25522427
[TBL] [Abstract][Full Text] [Related]
14. Captodiamine, a putative antidepressant, enhances hypothalamic BDNF expression in vivo by synergistic 5-HT2c receptor antagonism and sigma-1 receptor agonism.
Ring RM; Regan CM
J Psychopharmacol; 2013 Oct; 27(10):930-9. PubMed ID: 23863923
[TBL] [Abstract][Full Text] [Related]
15. Rapid-acting antidepressant-like effects of acetyl-l-carnitine mediated by PI3K/AKT/BDNF/VGF signaling pathway in mice.
Wang W; Lu Y; Xue Z; Li C; Wang C; Zhao X; Zhang J; Wei X; Chen X; Cui W; Wang Q; Zhou W
Neuroscience; 2015 Jan; 285():281-91. PubMed ID: 25463525
[TBL] [Abstract][Full Text] [Related]
16. Synaptic adaptations of CA1 pyramidal neurons induced by a highly effective combinational antidepressant therapy.
Marchetti C; Tafi E; Middei S; Rubinacci MA; Restivo L; Ammassari-Teule M; Marie H
Biol Psychiatry; 2010 Jan; 67(2):146-54. PubMed ID: 19892321
[TBL] [Abstract][Full Text] [Related]
17. Chronic fluoxetine treatment increases expression of synaptic proteins in the hippocampus of the ovariectomized rat: role of BDNF signalling.
O'Leary OF; Wu X; Castren E
Psychoneuroendocrinology; 2009 Apr; 34(3):367-81. PubMed ID: 18977602
[TBL] [Abstract][Full Text] [Related]
18. Macranthol promotes hippocampal neuronal proliferation in mice via BDNF-TrkB-PI3K/Akt signaling pathway.
Luo L; Liu XL; Li J; Mu RH; Liu Q; Yi LT; Geng D
Eur J Pharmacol; 2015 Sep; 762():357-63. PubMed ID: 26004527
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotection by Imipramine against lipopolysaccharide-induced apoptosis in hippocampus-derived neural stem cells mediated by activation of BDNF and the MAPK pathway.
Peng CH; Chiou SH; Chen SJ; Chou YC; Ku HH; Cheng CK; Yen CJ; Tsai TH; Chang YL; Kao CL
Eur Neuropsychopharmacol; 2008 Feb; 18(2):128-40. PubMed ID: 17566715
[TBL] [Abstract][Full Text] [Related]
20. Magnetic stimulation modulates structural synaptic plasticity and regulates BDNF-TrkB signal pathway in cultured hippocampal neurons.
Ma J; Zhang Z; Su Y; Kang L; Geng D; Wang Y; Luan F; Wang M; Cui H
Neurochem Int; 2013 Jan; 62(1):84-91. PubMed ID: 23201339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
